While posing potential and realized disruptions to a range of health services, the COVID-19 pandemic also drove the accelerated development of promising and responsive health service delivery innovations, two papers published this month in Clinical Infectious Diseases show.

Promoting the concept of “herd immunity” as framed in a recently circulated document as an answer to the COVID-19 pandemic is inappropriate, irresponsible and ill-informed. “Community immunity,” or “herd immunity,” a goal of vaccination campaigns, should never come at the cost of planned exposure to infection of millions of additional people

In a letter to the Centers for Medicare & Medicaid Services, the Infectious Diseases Society of America highlighted provisions in the agency’s 2021 Medicare Physician Fee Schedule and Quality Payment Program proposed rule affecting payments to infectious diseases physicians

The National Action Plan for Combating Antibiotic Resistant Bacteria, 2020-2025, released today by the Department of Health and Human Services builds on the first iteration of the plan with a One Health approach in critical areas.

While the ongoing impacts of COVID-19 continue to highlight needs for new and proven tools to combat the spread and effects of this novel coronavirus, the development, evaluation and use of treatment strategies must be guided by science.

The Infectious Diseases Society of America is pleased to announce Barbara Alexander, M.D., FIDSA, as the society’s new president beginning Oct. 25. Dr. Alexander will be joined by dedicated, experienced board members as well as newly elected representatives who will lead IDSA’s commitment to promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.